A single entry point to explore editorial content, institutional pages, team members, and scientific publications.
4 results "Article original"
New England Journal of Medicine • A randomized, double-blind, placebo-controlled phase III trial evaluating the efficacy of the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine regimen among healthcare workers and at-risk populations in the Democratic Republic of the Congo.
Open resource →The Lancet • Whole-genome sequencing of 248 Mpox virus isolates from 14 provinces in DRC reveals substantial genetic diversity and identifies novel clades with potential implications for vaccine efficacy.
Open resource →The Lancet Infectious Diseases • This multicentre randomised phase III trial demonstrates non-inferiority of oral fexinidazole compared to the standard NECT regimen for stage 2 HAT, with a cure rate of 95.2% vs 93.8% at 18 months.
Open resource →Parasite • Étude transversale évaluant la prévalence de la résistance aux pyréthrinoïdes chez Anopheles gambiae s.l. dans quatre zones de santé de Kinshasa à l'aide de tests OMS et de caractérisation moléculaire.
Open resource →